000 01885 a2200481 4500
005 20250518094703.0
264 0 _c20201006
008 202010s 0 0 eng d
022 _a1477-092X
024 7 _a10.1177/1078155219893441
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrazer, Morgan B
245 0 0 _aInternational Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care.
_h[electronic resource]
260 _bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_c04 2020
300 _a3-10 p.
_bdigital
500 _aPublication Type: Journal Article; Practice Guideline
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBiosimilar Pharmaceuticals
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPharmaceutical Services
_xorganization & administration
650 0 4 _aPharmacovigilance
700 1 _aBubalo, Joseph
700 1 _aPatel, Himanshu
700 1 _aSiderov, Jim
700 1 _aCubilla, Milagros
700 1 _aDe Lemos, Mário
700 1 _aDhillon, Harbans
700 1 _aHarchowal, Jatinder
700 1 _aKuchonthara, Nirachorn
700 1 _aLivinalli, Annemeri
700 1 _aMacedo, Rodrigo
700 1 _aMwangi, Winnie
700 1 _aNomura, Hisanaga
700 1 _aO'Connor, Shaun
700 1 _aPatterson, Maggie
700 1 _aSeadi Torriani, Mayde
700 1 _aYim, Barbara
700 1 _aChan, Alexandre
700 1 _aForeman, Emma
773 0 _tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_gvol. 26
_gno. 3_suppl
_gp. 3-10
856 4 0 _uhttps://doi.org/10.1177/1078155219893441
_zAvailable from publisher's website
999 _c30836160
_d30836160